首页> 外文OA文献 >544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)

【2h】

544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)

机译：544 Alopecia Areata病变显示出与口腔janus激酶抑制剂PF-06651600（JAK3）和PF-06700841（TYK2 / JAK1）相关的免疫和角蛋白生物标志物的显着变化

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
E. Guttman-Yassky; A.B. Pavel; K. Page; A. Diaz; A. Banerjee; B. King; W. Zhang; L. Zhu; C. Banfield; L.A. Cox; M. Vincent; M. Dowty; E. Peeva;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1) [J] . Guttman-Yassky E., Pavel A. B., Page K., The Journal of investigative dermatology. . 2019,第5Suppla1期

机译：Alopecia Areata病变显示免疫和角蛋白生物标志物的显着变化，与口腔janus激酶抑制剂pf-06651600（JAK3）和PF-06700841（TYK2 / JAK1）相关联的免疫和角蛋白生物标志物
2. Treatment of severe alopecia areata with the oral Janus kinase inhibitor, tofacitinib: A retrospective chart review [J] . Ibrahim O., Hogan S., Piliang M., The Journal of investigative dermatology. . 2017,第5期

机译：用口腔janus激酶抑制剂治疗严重脱发菌生长，Tofacitinib：回顾性图表综述
3. The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3 [J] . Lee Sun-Mi, Yoon Kyoung Bin, Lee Hyo Jeong, Bioorganic and medicinal chemistry . 2016,第21期

机译：发现三唑-吡咯并嘧啶的2,5-异构体相对于JAK1和JAK3为选择性Janus激酶2（JAK2）抑制剂
4. At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors [O] . Katerina Yale, Aunna Pourang, Maksim V. Plikus, 2020

机译：在2种脱发症的十字路口：口服Janus激酶抑制剂治疗斑秃患者的头发再生长的雄激素性脱发模式
5. Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1((2S,5R)5-((7HPyrrolo2,3dpyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans [O] . -1

机译：Janus激酶3（JAK3）特异性抑制剂1（（2S，5R）5 - （（7HPyrolo 2,3d嘧啶-4-基）氨基）-2-甲基哌啶-1-基）PROP-2-ZH -1-ONE（PF-06651600）允许在人类中询问JAK3信号

544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)

著录项

相似文献

相关主题

期刊订阅